Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant population - remains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care.

In this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused book is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia.

Definitions and scope of treatment-refractory schizophrenia

Biology of schizophrenia: Is treatment-refractoriness synonymous with severity of illness
Evolution of refractoriness
Medical and psychiatric comorbidities: Complicating treatment expectations
Overview of pharmacologic treatments and guidelines
Clozapine: Gold standard treatment for refractory schizophrenia: Now or never
Augmenting clozapine and other antipsychotic medications: Pharmacologic choices and differential outcomes
Augmenting clozapine therapy: Emerging neuromodulatory strategies
Cognitive remediation for refractory schizophrenia
Psychological and familial therapies for refractory schizophrenia
Vocational performance of patients with chronic schizophrenia
Refractory schizophrenia and the criminal justice system: A failure of continuity of care and a real challenge
Personalized medicine: A 'game changer' in the care of patients with treatment-refractory schizophrenia?